EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer

EPHA3, a member of the EPH family, is overexpressed in various cancers. We demonstrated previously that EPHA3 is associated with radiation resistance in head and neck cancer via the PTEN/Akt/EMT pathway; the inhibition of EPHA3 significantly enhances the efficacy of radiotherapy in vitro and in vivo...

Full description

Bibliographic Details
Main Authors: Song-Hee Kim, Byung-Chul Kang, Daseul Seong, Won-Hyeok Lee, Jae-Hee An, Hyoung-Uk Je, Hee-Jeong Cha, Hyo-Won Chang, Sang-Yoon Kim, Seong-Who Kim, Myung-Woul Han
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/4/599
_version_ 1797537283231973376
author Song-Hee Kim
Byung-Chul Kang
Daseul Seong
Won-Hyeok Lee
Jae-Hee An
Hyoung-Uk Je
Hee-Jeong Cha
Hyo-Won Chang
Sang-Yoon Kim
Seong-Who Kim
Myung-Woul Han
author_facet Song-Hee Kim
Byung-Chul Kang
Daseul Seong
Won-Hyeok Lee
Jae-Hee An
Hyoung-Uk Je
Hee-Jeong Cha
Hyo-Won Chang
Sang-Yoon Kim
Seong-Who Kim
Myung-Woul Han
author_sort Song-Hee Kim
collection DOAJ
description EPHA3, a member of the EPH family, is overexpressed in various cancers. We demonstrated previously that EPHA3 is associated with radiation resistance in head and neck cancer via the PTEN/Akt/EMT pathway; the inhibition of EPHA3 significantly enhances the efficacy of radiotherapy in vitro and in vivo. In this study, we investigated the mechanisms of PTEN regulation through EPHA3-related signaling. Increased DNA methyltransferase 1 (DNMT1) and enhancer of zeste homolog 2 (EZH2) levels, along with increased histone H3 lysine 27 trimethylation (H3K27me3) levels, correlated with decreased levels of PTEN in radioresistant head and neck cancer cells. Furthermore, PTEN is regulated in two ways: DNMT1-mediated DNA methylation, and EZH2-mediated histone methylation through EPHA3/C-myc signaling. Our results suggest that EPHA3 could display a novel regulatory mechanism for the epigenetic regulation of PTEN in radioresistant head and neck cancer cells.
first_indexed 2024-03-10T12:12:56Z
format Article
id doaj.art-d35491c7cd4a49b6a1e246e1abf306dd
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T12:12:56Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-d35491c7cd4a49b6a1e246e1abf306dd2023-11-21T16:06:51ZengMDPI AGBiomolecules2218-273X2021-04-0111459910.3390/biom11040599EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck CancerSong-Hee Kim0Byung-Chul Kang1Daseul Seong2Won-Hyeok Lee3Jae-Hee An4Hyoung-Uk Je5Hee-Jeong Cha6Hyo-Won Chang7Sang-Yoon Kim8Seong-Who Kim9Myung-Woul Han10Department of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, KoreaDepartment of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, KoreaDepartment of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, KoreaDepartment of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, KoreaDepartment of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, KoreaDepartment of Radiation Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, KoreaDepartment of Pathology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, KoreaDepartment of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, KoreaDepartment of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, KoreaDepartment of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, KoreaDepartment of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, KoreaEPHA3, a member of the EPH family, is overexpressed in various cancers. We demonstrated previously that EPHA3 is associated with radiation resistance in head and neck cancer via the PTEN/Akt/EMT pathway; the inhibition of EPHA3 significantly enhances the efficacy of radiotherapy in vitro and in vivo. In this study, we investigated the mechanisms of PTEN regulation through EPHA3-related signaling. Increased DNA methyltransferase 1 (DNMT1) and enhancer of zeste homolog 2 (EZH2) levels, along with increased histone H3 lysine 27 trimethylation (H3K27me3) levels, correlated with decreased levels of PTEN in radioresistant head and neck cancer cells. Furthermore, PTEN is regulated in two ways: DNMT1-mediated DNA methylation, and EZH2-mediated histone methylation through EPHA3/C-myc signaling. Our results suggest that EPHA3 could display a novel regulatory mechanism for the epigenetic regulation of PTEN in radioresistant head and neck cancer cells.https://www.mdpi.com/2218-273X/11/4/599head and neck cancerradioresistancePTENEPHA3C-mycDNMT1
spellingShingle Song-Hee Kim
Byung-Chul Kang
Daseul Seong
Won-Hyeok Lee
Jae-Hee An
Hyoung-Uk Je
Hee-Jeong Cha
Hyo-Won Chang
Sang-Yoon Kim
Seong-Who Kim
Myung-Woul Han
EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer
Biomolecules
head and neck cancer
radioresistance
PTEN
EPHA3
C-myc
DNMT1
title EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer
title_full EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer
title_fullStr EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer
title_full_unstemmed EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer
title_short EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer
title_sort epha3 contributes to epigenetic suppression of pten in radioresistant head and neck cancer
topic head and neck cancer
radioresistance
PTEN
EPHA3
C-myc
DNMT1
url https://www.mdpi.com/2218-273X/11/4/599
work_keys_str_mv AT songheekim epha3contributestoepigeneticsuppressionofpteninradioresistantheadandneckcancer
AT byungchulkang epha3contributestoepigeneticsuppressionofpteninradioresistantheadandneckcancer
AT daseulseong epha3contributestoepigeneticsuppressionofpteninradioresistantheadandneckcancer
AT wonhyeoklee epha3contributestoepigeneticsuppressionofpteninradioresistantheadandneckcancer
AT jaeheean epha3contributestoepigeneticsuppressionofpteninradioresistantheadandneckcancer
AT hyoungukje epha3contributestoepigeneticsuppressionofpteninradioresistantheadandneckcancer
AT heejeongcha epha3contributestoepigeneticsuppressionofpteninradioresistantheadandneckcancer
AT hyowonchang epha3contributestoepigeneticsuppressionofpteninradioresistantheadandneckcancer
AT sangyoonkim epha3contributestoepigeneticsuppressionofpteninradioresistantheadandneckcancer
AT seongwhokim epha3contributestoepigeneticsuppressionofpteninradioresistantheadandneckcancer
AT myungwoulhan epha3contributestoepigeneticsuppressionofpteninradioresistantheadandneckcancer